Ticker · held by 5 filers

TXG

10X Genomics Inc

All tracked filers currently holding TXG, ranked by position size. Each row links through to the filer's full portfolio.

Total value held

$363.2M

Total shares

21,036,712

Filers holding

5 · 7 positions

Caveat

long only · 13F-eligible managers only

Filers holding TXG

sorted by position size · click any filer to see their full portfolio

# Filer Class Shares Value (USD) % of port

1 ARK Invest · Cathie Wood Common Stock 12,667,369 $206.6M 1.37%

2 BlackRock · Larry Fink CL A COM 6,392,650 $124.3M 0.00%

3 Renaissance Technologies · Jim Simons (founder) CL A COM 1,550,539 $25.3M 0.04%

4 Bridgewater Associates · Ray Dalio (founder) CL A COM 177,734 $2.9M 0.01%

5 Citadel Advisors · Ken Griffin CL A COM 130,820 $2.1M 0.00%

6 Citadel Advisors · Ken Griffin CALLCL A COM 107,100 $1.7M 0.00%

7 Citadel Advisors · Ken Griffin PUTCL A COM 10,500 $171.3K 0.00%

What this is

This page reverses the usual 13F view: instead of "what does Buffett hold," it answers "who holds NVDA?" Across the dozen tracked filers, all current 13F-disclosed holders of TXG are listed, with the position size and what fraction of each filer's overall portfolio it represents.

Caveats: only the filers tracked here are included (~12 names) — not the whole 13F universe (~6,000 filers). Position values are at the most recent quarter-end, not current market price. Only long positions are visible; shorts and synthetics aren't.

v0.2 · 2026 · data via SEC EDGAR · CUSIP→ticker via OpenFIGI